NewYork-Presbyterian. The University Hospital of Columbia and Cornell.

Transplantation

Lung Transplant

Back to the Transplantation Home Page

Find a Transplant Doctor

The Center for Lung Disease and Transplantation at NewYork-Presbyterian Hospital provides comprehensive, coordinated, multidisciplinary care to adults and children with every type of lung disease. Patients are evaluated and treated at the Columbia University Medical Center (uptown) campus of NewYork-Presbyterian Hospital.

Organ Transplant
Program brochure
(click image to
open PDF)

Specialized programs within or affiliated with the Center for Lung Disease and Transplantation include:

• The Jo-Ann F. LeBuhn Center for Chest Disease
• High Risk Lung Assessment Program
• Thoracic Oncology Program
• Interventional Bronchoscopy and Endobronchial Therapy Program, for the treatment of endobronchial tumors or tracheobronchial obstructions
• Interstitial Lung Disease Program
• Pulmonary Hypertension Program
• Adult Cystic Fibrosis Program
• Lung Volume Reduction Program

Lung transplant
outcomes at NYP
and national
average (click
image to open PDF)

Doctors in these programs effectively treat patients with some conditions using less invasive alternatives that may enable patients to avoid transplantation or may serve as a bridge to lung transplantation and delay this difficult treatment option.

Who is Eligible?

Lung transplantation can prolong the lives of patients with severe pulmonary disease and no alternative treatment options, and dramatically improves their quality of life.

Transplantation is usually offered to patients who have end-stage lung failure and an expected survival of one to two years. End-stage lung failure can develop from the following diseases:

(click to enlarge)

• interstitial lung disease
• COPD
• cystic fibrosis
• pulmonary hypertension
• sarcoidosis

Expertise in Cystic Fibrosis

NewYork-Presbyterian is a leader in advancing techniques and patient selection criteria for lung transplantation in adults and children with cystic fibrosis (CF). As a result, the Hospital has the largest CF lung transplant program in the New York metropolitan area.

Although current management strategies reasonably control the disease for most children with CF into adulthood, lung transplantation offers extended survival in patients with advancing disease who have severe and irreversible airflow obstruction. Transplanted patients with CF may now undergo subsequent transplantation if their initial transplant fails.

Heart and Lung Transplants

Surgeons from the Heart Failure and Transplantation Program and the Center for Lung Disease and Transplantation at NewYork-Presbyterian collaborate to perform combination heart and lung transplants for patients who need both organs transplanted.